Meiya Pharm

Zhejiang Meiya Pharmaceutical is a leading Chinese pharmaceutical company specializing in the research, development, and large-scale production of nucleotides, nucleosides, and their derivatives. Founded in 1998 and headquartered in Sanmen, Zhejiang, the company provides high-quality active pharmaceutical ingredients (APIs) and intermediates for the global life sciences industry. Their product portfolio includes essential components such as Cytidine, Uridine, Adenosine, and Guanosine, which serve as critical building blocks for antiviral drugs, health supplements, and infant formula. Meiya Pharm is recognized for its advanced fermentation and enzymatic synthesis technologies, maintaining a significant market share in the nucleotide series. The company is publicly traded on the National Equities Exchange and Quotations (NEEQ) in China.